View Document Preview and Link Document Date: 2014-05-29 15:15:40 Open Document File Size: 124,23 KB Share Result on Facebook
City South San Francisco / Hanover / / Company Immune Tolerance Network Group / IgG / Novartis Pharmaceuticals Corporation / Bernstein / Cox / Genentech Inc. / Garrett AB / / Country United States / / Event Person Communication and Meetings / / Facility American College of Allergy / / IndustryTerm oral food challenge trial / treatment of eosinophil-associated gastrointestinal disorders / food allergy / / MedicalCondition adult atopic dermatitis / TB / JE / Atopic Dermatitis / Clin Exper Allergy / Severe Persistent Disease / Chronic Spontaneous Urticaria / recalcitrant atopic dermatitis / severe persistent asthma / moderate-to-severe allergic asthma / hives / perennial allergic rhinitis / Occupational Latex Allergy / rhinitis / Latex Allergy / Clin Exp Allergy / ragweed-induced seasonal allergic rhinitis / seasonal allergic rhinitis / refractory chronic urticaria / refractory atopic dermatitis / chronic urticaria / asthma / acute bronchospasm / spontaneous urticaria / eosinophil-associated gastrointestinal disorders / allergic asthma / Eosinophilic esophagitis / itching / chronic rhinosinusitis / ragweed-induced allergic rhinitis / food allergy / status asthmaticus / severe allergic asthma / severe adult atopic dermatitis / urticaria / patient’s asthma / peanut allergy / Uribe M. Eosinophilic gastroenteritis / symptomatic chronic idiopathic/spontaneous urticaria / childhood asthma / chronic idiopathic urticaria / / MedicalTreatment immunotherapy / Allergen immunotherapy / / Organization Food and Drug Administration / American Academy of Allergy / Asthma and Immunology / Dermatologists Therapy Guidelines and Audit Subcommittee / Joint Task Force on Practice Parameters / Joint Council of Allergy / Asthma and Immunology / the American College / British Association of Dermatologists Therapy Guidelines / / Person Fernandez-Anton Martinez / Ann Allergy / / / Position physician / prescribing physician / / Product fluticasone propionate / loratadine / Symbicort / mometasone furoate / theophylline / Advair Diskus / fexofenadine / Xolair / / ProvinceOrState California / / Technology antibodies / / URL http / SocialTag 
PRIOR AUTHORIZATION POLICY Xolair® (omalizumab injection for subcutaneous [SC] use Genentech/Novartis) To Initiate a Coverage Review, Call[removed]